我要投票 中联在医疗器械行业中的票数:7
· 外 推 电 报 ·
2024-11-22 11:51:35 星期五

【中联是哪个国家的品牌?】

中联是什么牌子?「中联」是 国药集团中联药业有限公司 旗下著名品牌。该品牌发源于湖北省武汉市,由创始人蒋焘在1998-04-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

国药中联有着悠久的历史,由拥有四百余年中医药历史并享誉全国的叶开泰、达仁堂、刘有余堂金同仁、九芝堂、陈太乙等为代表的192家中药店铺联合组建而成。1952年,在原武汉市中药饮片业同业公会的发动下,成立武汉市中联制药厂。1997年股份制改造,2002年成立集团公司,2011年底重组进入中国较大的健康产业平台――中国医药集团。经过60余年发展壮大,公司已形成包括中成药、化学制剂生产和销售、医药商业营运等在内的多种产业结构,成为集科研、生产、流通、外贸于一体的专业医药健康企业。

公司专注经典中药生产与销售。拥有注册产品300余个,有82个品种列入国家基本药物目录,有14个品种,其中战略大品种鳖甲煎丸有两千多年历史,为汉代张仲景经典古方,专治胁下癥块。公司产品涉足肝脏用药、呼吸系统用药、妇科用药、心脑血管用药等特色领域,已形成以鳖甲煎丸为代表的肝脏用药系列,以金叶败毒颗粒、鼻炎片、强力感冒片为代表的呼吸道用药系列,以脉君安片、心脑清软胶囊为代表的心脑血管用药系列,以加味生化颗粒为代表的妇科用药系列。

公司注重经典中药的系统深度开发。依托国药集团旗下中国医药工业研究总院研发平台,广泛开展国内、国际合作与交流,不断探索经典古方治病机理,研究新工艺,保障产品疗效,拥有多项自主知识产权,为公司的可持续发展奠定了坚实地基础。

公司营销网络遍布全国多省、自治区、直辖市,终端销售网点覆盖全国,主要品种出口日本、马来西亚、印尼、美国等国家和地区。公司不仅销售产品,同时专注于将中医药哲学(文化)、产品核心价值传递给医生和患者,使“中联”成为受医生和患者尊重的制药企业,为中国中医药的发展贡献力量。

公司在东湖高新技术开发区光谷生物城按照现代中药生产标准兴建的“中联中医药产业园”已经建成,未来,公司将以此为依托,以“挖掘传承创新发扬中国中药,为‘家人’提供经典好中药”为已任,传承发扬中国中药,力争成为国内优秀现代化中药企业。十三五末营业收入过十亿元,利润过亿元。


英文翻译:Sinopharm has a long history. It is composed of 192 traditional Chinese medicine stores represented by Ye Kaitai, Da Rentang, Liu youyutang, Jin Tongren, Jiuzhitang and Chen Taiyi, who have more than 400 years of traditional Chinese medicine history and are well-known throughout the country. In 1952, Wuhan Zhonglian pharmaceutical factory was established under the initiative of the former Wuhan herbal medicine industry association. In 1997, the joint-stock system was reformed, and the group company was established in 2002. At the end of 2011, it was reorganized into China's larger health industry platform, China Pharmaceutical Group. After more than 60 years of development and expansion, the company has formed a variety of industrial structures, including the production and sales of Chinese patent medicine, chemical preparations, pharmaceutical commercial operation, etc., and has become a professional pharmaceutical health enterprise integrating scientific research, production, circulation and foreign trade. The company focuses on the production and sales of classic Chinese medicine. There are more than 300 registered products, 82 varieties are listed in the national basic drug catalog, and 14 varieties, of which the strategic big variety Biejiajian Pill has a history of more than 2000 years. It is a classic ancient recipe of Zhang Zhongjing in Han Dynasty and specializes in treating hypochondriac diseases. The company's products are involved in the fields of liver medicine, respiratory system medicine, gynecology medicine, cardio cerebral vascular medicine, etc. it has formed a series of liver medicine represented by Biejiajian Pill, respiratory medicine represented by Jinyebaidu granule, Biyan tablet, qiangliganmao tablet, cardio cerebral vascular medicine represented by maijunan tablet and xinnaoqing soft capsule, and Jiawei biochemical granule The representative series of gynecological medicine. The company pays attention to the systematic and in-depth development of traditional Chinese medicine. Relying on the R & D platform of China Pharmaceutical Industry Research Institute under Sinopharm group, the company has extensively carried out domestic and international cooperation and exchanges, constantly explored the mechanism of classical ancient prescriptions, studied new technologies, guaranteed the product efficacy, and possessed a number of independent intellectual property rights, laying a solid foundation for the company's sustainable development. The company's marketing network covers many provinces, autonomous regions and municipalities directly under the central government, and the terminal sales outlets cover the whole country. The main products are exported to Japan, Malaysia, Indonesia, the United States and other countries and regions. The company not only sells products, but also focuses on delivering the Philosophy (Culture) and core values of traditional Chinese medicine to doctors and patients, making Zoomlion a pharmaceutical enterprise respected by doctors and patients and contributing to the development of traditional Chinese medicine in China. The "Zhonglian traditional Chinese medicine industrial park" built by the company in the Guanggu biological city of Donghu high tech Development Zone in accordance with the production standards of modern traditional Chinese medicine has been completed. In the future, the company will take this as the support, take "mining, inheriting, innovating and carrying forward Chinese traditional medicine, providing classic and good traditional Chinese medicine for" family "as the responsibility, inherit and carry forward Chinese traditional medicine, and strive to become an excellent modern Chinese medicine enterprise in China. At the end of the 13th five year plan, the operating revenue was over one billion yuan and the profit was over one billion yuan.

本文链接: https://www.waitui.com/brand/9f77d79a5.html 联系电话:027819389818805

千城特选小程序码

7×24h 快讯

国家数据局:优化网络计费方式,降低东西部数据传输成本,促进东部中高时延业务向西部转移

36氪获悉,国家数据局向社会公开征求《国家数据基础设施建设指引(征求意见稿)》意见。其中提到,推进东中西部算力协同。加强新兴网络技术创新应用,优化网络计费方式,降低东西部数据传输成本,促进东部中高时延业务向西部转移。构建算力多级调度策略引擎,实现跨平台、跨层级、跨区域的算力资源混合部署和统一调度,促进算力资源高效对接,提升数据汇聚、处理、流通、交易效率。推动国家枢纽节点和需求地之间400G/800G高带宽全光连接,引导电信运营商提升“公共传输通道”效能,推进算网深度融合。

2小时前

国家数据局:推动实现“瓦特”产业向“比特”产业转化,不断壮大数算产业生态体系

36氪获悉,国家数据局向社会公开征求《国家数据基础设施建设指引(征求意见稿)》意见。其中提到,推进算力与数据、算法融合创新。推动实现“瓦特”产业向“比特”产业转化,不断壮大数算产业生态体系,助力打造具有国际竞争力的数字产业集群。推动行业数据和算力协同,实现数据可信流通,提升数据处理能力和治理水平。建立健全算法开发利用机制,积极开展大模型创新算法及关键技术研究,提升数据分析能力,降低大模型计算的算力消耗水平。

2小时前

国家数据局:建立健全数据基础制度体系,加快出台数据产权、流通交易、收益分配、安全治理等政策文件

36氪获悉,国家数据局向社会公开征求《国家数据基础设施建设指引(征求意见稿)》意见。其中提到,健全政策保障体系。建立健全数据基础制度体系,加快出台数据产权、流通交易、收益分配、安全治理等政策文件。在新型基础设施规划安排下,研究制定国家数据基础设施建设规划。加大中央投资对国家数据基础设施建设的支持力度。各地区、各部门要在数据基础设施规划布局、资金安排、课题研究方面给予重点支持。积极引导社会资本力量参与国家数据基础设施建设。

2小时前

游戏股异动拉升,富春股份直线涨停

36氪获悉,截至发稿,游戏股异动拉升,富春股份直线涨停,盛天网络、星辉娱乐、冰川网络、姚记科技、大晟文化等纷纷走强。

2小时前

腾讯出售超4亿美元Reddit股票

社交媒体公司Reddit股价在周四盘后下跌7.29%,此前腾讯披露称该公司出售了对Reddit的大量持股。根据提交给美国证券交易委员会(SEC)的文件,腾讯11月19日以平均每股133.76美元的价格出售了65.50万股Reddit股票,在11月14日至11月18日期间以平均每股约129.38美元的价格出售了88.26万股,在11月11日至13日以平均每股132.19美元的价格出售了近150万股。在总计价值超4亿美元的抛售后,腾讯对Reddit的持股减至775万股。(界面)

2小时前

本页详细列出关于WEGO威高的品牌信息,含品牌所属公司介绍,WEGO威高所处行业的品牌地位及优势。
咨询